ICON PLC (ICLR): Price and Financial Metrics

ICON PLC (ICLR): $208.58

0.83 (+0.40%)

POWR Rating

Component Grades














  • Sentiment is the dimension where ICLR ranks best; there it ranks ahead of 92.32% of US stocks.
  • ICLR's strongest trending metric is Stability; it's been moving up over the last 178 days.
  • ICLR's current lowest rank is in the Quality metric (where it is better than 20.56% of US stocks).

ICLR Stock Summary

  • ICLR has a market capitalization of $16,978,068,551 -- more than approximately 89.03% of US stocks.
  • The price/operating cash flow metric for ICON PLC is higher than 84.82% of stocks in our set with a positive cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, ICON PLC is reporting a growth rate of 110.76%; that's higher than 87.51% of US stocks.
  • If you're looking for stocks that are quantitatively similar to ICON PLC, a group of peers worth examining would be FWONA, MOS, LBRDA, H, and NXST.
  • ICLR's SEC filings can be seen here. And to visit ICON PLC's official web site, go to www.iconplc.com.

ICLR Valuation Summary

  • ICLR's price/sales ratio is 2.2; this is 15.79% higher than that of the median Healthcare stock.
  • Over the past 243 months, ICLR's EV/EBIT ratio has gone up 13.5.

Below are key valuation metrics over time for ICLR.

Stock Date P/S P/B P/E EV/EBIT
ICLR 2023-03-17 2.2 2.0 33.6 27.0
ICLR 2023-03-16 2.3 2.1 34.5 27.6
ICLR 2023-03-15 2.2 2.0 33.9 27.2
ICLR 2023-03-14 2.3 2.1 34.8 27.8
ICLR 2023-03-13 2.2 2.0 34.3 27.4
ICLR 2023-03-10 2.3 2.1 34.6 27.7

ICLR Growth Metrics

    Its 5 year net income to common stockholders growth rate is now at 39.45%.
  • Its 2 year net income to common stockholders growth rate is now at -55.47%.
  • Its 4 year cash and equivalents growth rate is now at 103.28%.
ICLR's revenue has moved up $4,970,206,000 over the prior 30 months.

The table below shows ICLR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 7,741.386 563.315 505.304
2022-09-30 7,664.505 912.559 464.326
2022-09-30 7,664.505 912.559 464.326
2022-06-30 7,588.43 997.754 209.902
2022-06-30 7,588.43 997.754 209.902
2022-03-31 6,524.392 944.138 168.033

ICLR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ICLR has a Quality Grade of B, ranking ahead of 84.72% of graded US stocks.
  • ICLR's asset turnover comes in at 0.882 -- ranking 150th of 561 Business Services stocks.
  • 500 - Internal server error

The table below shows ICLR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 0.882 0.292 0.489
2019-12-31 1.067 0.296 0.542
2018-12-31 1.153 0.300 0.447
2017-12-31 0.885 0.416 0.420
2016-12-31 0.940 0.423 0.403
2015-12-31 0.970 0.423 0.516

ICLR Price Target

For more insight on analysts targets of ICLR, see our ICLR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $205.14 Average Broker Recommendation 1.72 (Moderate Buy)

ICLR Stock Price Chart Interactive Chart >

Price chart for ICLR

ICLR Price/Volume Stats

Current price $208.58 52-week high $263.62
Prev. close $207.75 52-week low $171.43
Day low $203.24 Volume 674,900
Day high $209.62 Avg. volume 525,096
50-day MA $226.39 Dividend yield N/A
200-day MA $213.27 Market Cap 17.05B

ICON PLC (ICLR) Company Bio

ICON Public Limited Company provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company was founded in 1990 and is based in Dublin, Ireland.

ICLR Latest News Stream

Event/Time News Detail
Loading, please wait...

ICLR Latest Social Stream

Loading social stream, please wait...

View Full ICLR Social Stream

Latest ICLR News From Around the Web

Below are the latest news stories about ICON PLC that investors may wish to consider to help them evaluate ICLR as an investment opportunity.

Does The Market Have A Low Tolerance For ICON Public Limited Company's (NASDAQ:ICLR) Mixed Fundamentals?

It is hard to get excited after looking at ICON's (NASDAQ:ICLR) recent performance, when its stock has declined 9.2...

Yahoo | March 13, 2023

LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology

BALLERUP, Denmark & DUBLIN, March 10, 2023--LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition of building one of the most effective and efficient clinical portfolio execution organisations in the industry.

Yahoo | March 10, 2023

ICON plc to Present at Upcoming Investor Conferences

DUBLIN, February 27, 2023--ICON plc to Present at Upcoming Investor Conferences

Yahoo | February 27, 2023

ICON Full Year 2022 Earnings: EPS Misses Expectations

ICON ( NASDAQ:ICLR ) Full Year 2022 Results Key Financial Results Revenue: US$7.74b (up 41% from FY 2021). Net income...

Yahoo | February 24, 2023

Icon PLC (ICLR) Surpasses Q4 Earnings and Revenue Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of 2.29% and 0.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2023

Read More 'ICLR' Stories Here

ICLR Price Returns

1-mo -8.34%
3-mo 5.64%
6-mo 9.19%
1-year -12.81%
3-year 72.04%
5-year 77.03%
YTD 7.38%
2022 -37.28%
2021 58.84%
2020 13.21%
2019 33.29%
2018 15.21%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7142 seconds.